Are the MDS-UPDRS-Based Composite Scores Clinically Applicable?

Area of Science:

• Neurology
• Clinical Outcome Measures
• Movement Disorders

Background:

• The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) is a key clinical assessment tool.
• Establishing reliable composite scores is crucial for tracking Parkinson's disease progression.

Purpose of the Study:

• To assess the feasibility of using various composite scores based on the MDS-UPDRS.
• To determine the minimal clinically important difference (MCID) thresholds for these composite scores.

Main Methods:

• Analysis of 1,113 paired patient investigations from 452 individuals.
• Application of three distinct evaluation techniques concurrently.
• Utilized ordinal regression modeling to establish thresholds.

Main Results:

• MDS-UPDRS II+III, MDS-UPDRS I+II+III, and the total MDS-UPDRS score are clinically applicable.
• MCID for MDS-UPDRS II+III: >4.9 points improvement, >4.2 points worsening.
• MCID for MDS-UPDRS I+II+III: >6.7 points improvement, >5.2 points worsening.
• MCID for total MDS-UPDRS: >7.1 points improvement, >6.3 points worsening.

Conclusions:

• The study validates the use of composite scores derived from the MDS-UPDRS.
• These findings support the application of these composite scores in clinical practice and research.